Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
World Journal of Urology|July 20, 2020
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsiesMatteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 10, 2022
Percutaneous thermal ablation for cT1 renal mass in solitary kidney: A multicenter trifecta comparative analysis versus robot-assisted partial nephrectomySavio Domenico Pandolfo, Davide Loizzo, Alp T Beksac, et al.
Medicine|November 19, 2015
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell CarcinomaGiuseppe Lucarelli, Monica Rutigliano, Francesca Sanguedolce, et al.
Minerva Urology and Nephrology|November 17, 2020
Robot-assisted partial nephrectomy: 7-year outcomesUmberto Carbonara, Giuseppe Simone, Umberto Capitanio, et al.
Journal of Nephrology|May 23, 2024
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort studySimona Simone, Virginia Pronzo, Francesco Pesce, et al.
Aging|April 20, 2021
Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injuryChiara Divella, Alessandra Stasi, Rossana Franzin, et al.
BMC Cancer|November 12, 2017
Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" studyLuca Cindolo, Clara Natoli, Cosimo De Nunzio, et al.
Urologia Internationalis|June 24, 2021
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic BiopsiesMatteo Ferro, Daniela Terracciano, Gennaro Musi, et al.
Therapeutic Advances in Urology|August 5, 2025
Artificial intelligence and radiomics applications in adrenal lesions: a systematic reviewMatteo Ferro, Octavian Sabin Tataru, Giuseppe Carrieri, et al.
Clinical Genitourinary Cancer|January 16, 2022
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort AnalysisMatteo Ferro, Sever Chiujdea, Gennaro Musi, et al.
Pageof 16